JNJ Kronos AI forecast
A 30-trading-day price forecast for Johnson & Johnson (JNJ) from Kronos AI, an open-source foundation model trained on candlestick charts.
Kronos AI's median forecast puts Johnson & Johnson at $253.21 on 2026-12-08, −5.8% from the last close of $268.73 on 2026-10-27. Eight out of ten sampled paths end between $239.78 and $261.92, and 0 of the 8 paths finish above today's price.
Forecast path
median, with the 10–90% band of the sampled pathsOpen the interactive forecast → Full analysis of JNJ
The forecast, week by week
| Date | Median | Low (10%) | High (90%) |
|---|---|---|---|
| 2026-11-03 | $268.88 | $264.22 | $277.03 |
| 2026-11-10 | $267.10 | $259.06 | $273.94 |
| 2026-11-17 | $259.20 | $250.71 | $267.38 |
| 2026-11-24 | $255.98 | $248.11 | $271.50 |
| 2026-12-01 | $255.87 | $243.95 | $264.10 |
| 2026-12-08 | $253.21 | $239.78 | $261.92 |
What is Kronos AI?
Kronos is an open-source foundation model for financial candlesticks, pre-trained on K-line data from more than 45 exchanges. Gnzub runs it on each stock's last 120 daily bars and samples several possible futures, so the forecast is a range of outcomes rather than one confident line. It is a statistical model, not an analyst: it reads price patterns only and knows nothing about news, earnings or the business.
Questions
- What is the Kronos AI forecast for JNJ?
- Kronos AI's median forecast for JNJ is $253.21 in 30 trading days, −5.8% from the last close, with a 10–90% range of $239.78 to $261.92.
- Is the JNJ Kronos forecast a buy or sell signal?
- No. It is the output of a statistical model that reads price history only. It is not investment advice, and the range shows how uncertain the model is.
- How often is the forecast updated?
- The forecasts are regenerated regularly; this one starts from the close of 2026-10-27.
Kronos forecasts for similar companies
- LLY — Eli Lilly and Company
- ABBV — AbbVie Inc.
- MRK — Merck & Company Inc.
- NVS — Novartis AG
- AZN — AstraZeneca PLC
- ABT — Abbott Laboratories